Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,702.00    52.00 (1.42%)
Bid:
3,698.00
Ask:
3,726.00
Spread: 28.00 (0.757%)
Market Cap: £1.04b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

US Tax Reform

9 Jan 2018 07:00

RNS Number : 2812B
4imprint Group PLC
09 January 2018
 

4imprint Group plc

9 January 2018

 

Impact on 4imprint from US Tax Reform

 

4imprint Group plc (the "Group"), the leading international direct marketer of promotional products, today provides guidance on the expected impact on the Group from recent US tax legislation, ("US Tax Reform").

 

Given that most of 4imprint's operations (97% of Group revenue) are based in the USA, the Board expects that US Tax Reform will have a beneficial impact on the Group's prospective financial position.

 

For the year ended 30 December 2017, no change is expected to the Group effective tax rate previously guided at c.30%. The revaluation of relevant non-cash deferred tax items at the new US corporate tax rate is not expected to produce a material effect on the Group's 2017 financial statements.

 

For the 2018 financial year and beyond, however, the reduction in the Federal tax rate from 35% to 21% is expected to have a positive impact on the Group's financial results. Initial projections indicate that the Group's effective tax rate would decrease from c.30% in 2017, settling in the low 20's% from 2018 onwards. This would result in a beneficial impact on earnings per share calculations. In addition, substantially all of the rate change is likely to translate into lower tax payments, thereby enhancing the cash generation capability of the Group.

 

The final US Tax Reform legislation is extensive and complex, and the full implications for the Group are still being analysed. It is anticipated that more detailed guidance will be given at the time of the announcement of the Group's final results in early March 2018. In the meantime, the Group plans to issue its usual January trading update on 17 January 2018.

 

For further information, please contact:

 

4imprint Group plc MHP Communications

Tel: + 44 (0) 20 7299 7201 Tel: + 44 (0) 20 3128 8794

 

Kevin Lyons-Tarr, Chief Executive Officer Katie Hunt

 

David Seekings, Chief Financial Officer Nessyah Hart

 

Note: This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUWOBRWUAARAR
Date   Source Headline
9th Jun 20261:58 pmRNSHolding(s) in Company
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase
18th Oct 20247:00 amRNSDirectorate Change
17th Sep 20248:32 amRNSEBT Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.